Elanco Animal Health Incorporated Common Stock
ELANElanco Animal Health Incorporated is a global company focused on developing, manufacturing, and marketing products for animal health. It specializes in veterinary pharmaceuticals, vaccines, and nutritional products aimed at enhancing the health and well-being of pets and livestock. Founded in 1954 and headquartered in Greenfield, Indiana, Elanco serves a broad customer base across multiple markets, emphasizing innovation in animal healthcare.
Company News
The global canine glucosamine supplement market is experiencing rapid growth, expanding from USD 236.44 million in 2025 to USD 257.55 million in 2026, with a projected CAGR of 7.27% through 2032, reaching USD 386.54 million. Market growth is driven by increased pet ownership, higher consumer spending on veterinary wellness, product innovation in ...
The global canine vaccines market is projected to grow from USD 2.05 billion in 2025 to USD 3.45 billion by 2033, with a CAGR of 6.79%. Growth is driven by rising pet ownership, increased awareness of preventive animal healthcare, and higher veterinary spending. Core vaccines and rabies vaccines lead by market share, while combination vaccines an...
The global diesel generator market is projected to grow at a CAGR of 5.28% from 2026 to 2032, reaching USD 27.42 billion by 2032 from USD 18.17 billion in 2024. Growth is driven by industrialization, infrastructure development, rising power outages, and data center expansion. However, the market faces headwinds from stringent environmental regula...
Virbac has acquired a specialized liquid medication for feline hyperthyroidism from Norbrook for around £100 million. The product, currently generating €14 million in revenue, will be distributed under the Thyronorm and Felanorm brands across multiple markets.
Virbac has acquired an innovative drug from Norbrook to treat feline hyperthyroidism, valued at £100 million. The product will be distributed under Thyronorm and Felanorm brands across multiple countries, targeting a growing market of senior cats with this common endocrine disease.
